EGFR and glioma: These bioconjugates were administered intracerebrally by means of CED to rats bearing receptor positive F98 gliomas that have been transfected with the human gene encoding EGFR or EGFRvIII (F98EGFR or F98EGFRvIII) [64–66, 79, 80].